Published in N Engl J Med on November 23, 2000
Association of race and age with survival among patients undergoing dialysis. JAMA (2011) 5.82
Environmental health disparities: a framework integrating psychosocial and environmental concepts. Environ Health Perspect (2004) 4.28
Racial variation in medical outcomes among living kidney donors. N Engl J Med (2010) 3.60
Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol (2008) 2.96
Neighborhood poverty and racial disparities in kidney transplant waitlisting. J Am Soc Nephrol (2009) 2.45
Influence of race, ethnicity and socioeconomic status on kidney disease. Nat Rev Nephrol (2012) 1.67
Racial disparities in pediatric access to kidney transplantation: does socioeconomic status play a role? Am J Transplant (2012) 1.59
Relationship between patients' perceptions of disadvantage and discrimination and listing for kidney transplantation. Am J Public Health (2002) 1.51
Outcomes of simultaneous pancreas-kidney transplantation in type 2 diabetic recipients. Clin J Am Soc Nephrol (2011) 1.49
Race, Relationship and Renal Diagnoses After Living Kidney Donation. Transplantation (2015) 1.45
Outcome disparities between African Americans and Caucasians in contemporary kidney transplant recipients. Am J Surg (2016) 1.39
Addressing racial and ethnic disparities in live donor kidney transplantation: priorities for research and intervention. Semin Nephrol (2010) 1.39
Framing disparities along the continuum of care from chronic kidney disease to transplantation: barriers and interventions. Am J Transplant (2009) 1.22
Trends in kidney transplantation rates and disparities. J Natl Med Assoc (2007) 1.14
Promoting access to renal transplantation: the role of social support networks in completing pre-transplant evaluations. J Gen Intern Med (2008) 1.08
The "House Calls" trial: a randomized controlled trial to reduce racial disparities in live donor kidney transplantation: rationale and design. Contemp Clin Trials (2012) 1.07
Similar outcomes among black and white renal allograft recipients. J Am Soc Nephrol (2008) 1.07
Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation. Clin J Am Soc Nephrol (2010) 1.00
Diabetes mellitus and hypertension: key risk factors for kidney disease. J Natl Med Assoc (2002) 1.00
Risk of end-stage renal disease among liver transplant recipients with pretransplant renal dysfunction. Am J Transplant (2012) 1.00
Completion of advanced care directives is associated with willingness to donate. J Natl Med Assoc (2006) 0.96
The RaDIANT community study protocol: community-based participatory research for reducing disparities in access to kidney transplantation. BMC Nephrol (2014) 0.96
Disparities in the provision of medical care: an outcome in search of an explanation. J Behav Med (2009) 0.94
Ethnic advantages in kidney transplant outcomes: the Hispanic Paradox at work? Nephrol Dial Transplant (2008) 0.91
Donor ethnicity influences outcomes following deceased-donor kidney transplantation in black recipients. J Am Soc Nephrol (2008) 0.90
The providing resources to enhance African American patients' readiness to make decisions about kidney disease (PREPARED) study: protocol of a randomized controlled trial. BMC Nephrol (2012) 0.90
Racial and ethnic disparities in renal transplantation. J Natl Med Assoc (2005) 0.90
Herpes zoster incidence in a multicenter cohort of solid organ transplant recipients. Transpl Infect Dis (2011) 0.89
Transition from donor candidates to live kidney donors: the impact of race and undiagnosed medical disease states. Clin Transplant (2011) 0.87
Racial and ethnic differences in mortality in children awaiting heart transplant in the United States. Am J Transplant (2009) 0.87
Can focusing on self-care reduce disparities in kidney transplantation outcomes? Am J Kidney Dis (2005) 0.85
Perceived discrimination predicts longer time to be accepted for kidney transplant. Transplantation (2012) 0.84
Predictors of having a potential live donor: a prospective cohort study of kidney transplant candidates. Am J Transplant (2009) 0.83
Genotype-guided tacrolimus dosing in African-American kidney transplant recipients. Pharmacogenomics J (2015) 0.82
Assessment of variation in live donor kidney transplantation across transplant centers in the United States. Transplantation (2011) 0.82
Feasibility and acceptability of the TALK social worker intervention to improve live kidney transplantation. Health Soc Work (2012) 0.81
Low C-reactive protein levels in a traditional West-African population living in a malaria endemic area. PLoS One (2013) 0.81
The role of minority geographic distribution in waiting time for deceased donor kidney transplantation. Am J Transplant (2014) 0.80
Racial disparities in reaching the renal transplant waitlist: is geography as important as race? Clin Transplant (2015) 0.80
Effect of Replacing Race with Apolipoprotein L1 Genotype in Calculation of Kidney Donor Risk Index. Am J Transplant (2016) 0.80
Patient-Centered mHealth Living Donor Transplant Education Program for African Americans: Development and Analysis. JMIR Res Protoc (2015) 0.79
Access to Kidney Transplantation among HIV-Infected Waitlist Candidates. Clin J Am Soc Nephrol (2017) 0.78
Overall Graft Loss Versus Death-Censored Graft Loss: Unmasking the Magnitude of Racial Disparities in Outcomes Among US Kidney Transplant Recipients. Transplantation (2016) 0.78
Readiness of wait-listed black patients to pursue live donor kidney transplant. Prog Transplant (2014) 0.78
Sirolimus pharmacokinetics in early postmyeloablative pediatric blood and marrow transplantation. Biol Blood Marrow Transplant (2012) 0.77
Chronic Renal Transplant Rejection and Possible Anti-Proliferative Drug Targets. Cureus (2015) 0.76
Invariance of measures to understand decision-making for pursuing living donor kidney transplant. J Health Psychol (2015) 0.76
Distance from treatment facility and risk of death from cardiovascular and infectious causes in renal transplant patients. Indian J Nephrol (2013) 0.75
Factors affecting willingness to receive a kidney transplant among minority patients at an urban safety-net hospital: a cross-sectional survey. BMC Nephrol (2015) 0.75
Racial and Ethnic Disparities in Graft and Recipient Survival in Elderly Kidney Transplant Recipients. J Am Geriatr Soc (2015) 0.75
How is organ transplantation depicted in internal medicine and transplantation journals. BMC Med Ethics (2013) 0.75
Profiling risk for acute rejection in kidney transplantation: recipient age is a robust risk factor. J Nephrol (2016) 0.75
Consensus statement on the live organ donor. JAMA (2000) 3.29
Report of a National Conference on Donation after cardiac death. Am J Transplant (2006) 3.04
The evaluation of renal transplant candidates: clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol (1995) 2.32
Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65
Evaluation of living renal donors. The current practice of US transplant centers. Transplantation (1995) 1.47
The evaluation of living renal transplant donors: clinical practice guidelines. Ad Hoc Clinical Practice Guidelines Subcommittee of the Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol (1996) 1.46
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation (1998) 1.36
Report of a consensus conference on transplant program quality and surveillance. Am J Transplant (2012) 1.18
Kidneys at higher risk of discard: expanding the role of dual kidney transplantation. Am J Transplant (2014) 1.15
Progress in renal transplantation. A single center study of 3359 patients over 25 years. Ann Surg (1995) 1.07
The living donor process in kidney transplantation: influence of race and comorbidity. Transplant Proc (1997) 0.92
AST/ASTS workshop on increasing organ donation in the United States: creating an "arc of change" from removing disincentives to testing incentives. Am J Transplant (2015) 0.89
Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis. J Am Soc Nephrol (1998) 0.88
Living donor nephrectomy: understanding long-term risk in minority populations. Am J Transplant (2010) 0.87
Tapering or discontinuing cyclosporine for financial reasons--a single-center experience. Am J Kidney Dis (1993) 0.85
Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis. Kidney Int (1994) 0.85
Analysis of 22 years experience in living-related transplantation at the University of Alabama in Birmingham. Clin Transpl (1991) 0.85
Tolerance in renal transplantation after allogeneic bone marrow transplantation-6-year follow-up. Transplantation (2001) 0.83
Postransplant lymphoproliferative disorder localized near the allograft in renal transplantation. Transplantation (2000) 0.81
Dilemmas in renal transplantation: when the clinical course and histological findings differ. Am J Kidney Dis (1996) 0.80
Benefits of quadruple immunosuppressive therapy in recipients of living related donor kidneys. A review of 855 operations. Ann Surg (1992) 0.79
Experience with mycophenolate mofetil (RS61443) in renal transplantation at a single center. Ann Surg (1993) 0.78
Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients. Clin Transpl (1990) 0.78
Benefits of continued cyclosporine through an indigent drug program. Am J Kidney Dis (1996) 0.77
Counseling patients for kidney transplantation: awkward conversations? Am J Transplant (2011) 0.77
Prediction of renal transplant survival from early postoperative radioisotope studies. J Nucl Med (2000) 0.77
Captopril-induced fall in glomerular filtration rate in cyclosporine-treated hypertensive patients. J Am Soc Nephrol (1993) 0.76
Renal transplantation in African-American recipients: three decades at a single center. Transplant Proc (1997) 0.76
Pentoxifylline does not prevent the cytokine-induced first dose reaction following OKT3--a randomized, double-blind placebo-controlled study. Transplantation (1996) 0.75
HLA matching in renal transplantation. N Engl J Med (1995) 0.75
The conspicuous costs of more of the same. Am J Transplant (2006) 0.75
Stumbling toward equity: the role of government in kidney transplantation. Univ Ill Law Rev (1998) 0.75
The impact of the UNOS mandatory sharing policy on recipients of the black and white races--experience at a single renal transplant center. Transplantation (1992) 0.75
Report of a joint ESOT and AST meeting: highlights in biologic agents and transplantation. Am J Transplant (2011) 0.75